Cargando…

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion

Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male. He had a history of a cough for several weeks and had visited...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Eiji, Takahashi, Naoki, Morizumi, Shun, Tamiya, Hiroyuki, Matsuoka, Hisashi, Kuroda, Naoto, Yorita, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529565/
https://www.ncbi.nlm.nih.gov/pubmed/32894005
http://dx.doi.org/10.1111/1759-7714.13652
_version_ 1783589460714192896
author Takeuchi, Eiji
Takahashi, Naoki
Morizumi, Shun
Tamiya, Hiroyuki
Matsuoka, Hisashi
Kuroda, Naoto
Yorita, Kenji
author_facet Takeuchi, Eiji
Takahashi, Naoki
Morizumi, Shun
Tamiya, Hiroyuki
Matsuoka, Hisashi
Kuroda, Naoto
Yorita, Kenji
author_sort Takeuchi, Eiji
collection PubMed
description Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male. He had a history of a cough for several weeks and had visited a local doctor. Left pleural effusion was noted, and the patient was referred to our hospital. He was diagnosed with malignant pleural mesothelioma by pleural biopsy, with eosinophilic pleural effusion. IL‐5 in the pleural effusion increased, and tumor cells were IL‐5‐positive by immunostaining. There have been few reports of IL‐5‐producing tumors, and this is the first report of IL‐5‐producing malignant pleural mesothelioma. Host‐tumor cell interactions cause eosinophilic pleural effusion. In patients with eosinophilic pleural effusion, malignant pleural effusion should be considered. It is necessary to clarify the pathophysiology of malignant tumors and eosinophils.
format Online
Article
Text
id pubmed-7529565
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-75295652020-10-05 Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion Takeuchi, Eiji Takahashi, Naoki Morizumi, Shun Tamiya, Hiroyuki Matsuoka, Hisashi Kuroda, Naoto Yorita, Kenji Thorac Cancer Case Reports Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male. He had a history of a cough for several weeks and had visited a local doctor. Left pleural effusion was noted, and the patient was referred to our hospital. He was diagnosed with malignant pleural mesothelioma by pleural biopsy, with eosinophilic pleural effusion. IL‐5 in the pleural effusion increased, and tumor cells were IL‐5‐positive by immunostaining. There have been few reports of IL‐5‐producing tumors, and this is the first report of IL‐5‐producing malignant pleural mesothelioma. Host‐tumor cell interactions cause eosinophilic pleural effusion. In patients with eosinophilic pleural effusion, malignant pleural effusion should be considered. It is necessary to clarify the pathophysiology of malignant tumors and eosinophils. John Wiley & Sons Australia, Ltd 2020-09-07 2020-10 /pmc/articles/PMC7529565/ /pubmed/32894005 http://dx.doi.org/10.1111/1759-7714.13652 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Takeuchi, Eiji
Takahashi, Naoki
Morizumi, Shun
Tamiya, Hiroyuki
Matsuoka, Hisashi
Kuroda, Naoto
Yorita, Kenji
Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
title Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
title_full Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
title_fullStr Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
title_full_unstemmed Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
title_short Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
title_sort interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529565/
https://www.ncbi.nlm.nih.gov/pubmed/32894005
http://dx.doi.org/10.1111/1759-7714.13652
work_keys_str_mv AT takeuchieiji interleukin5producingmalignantpleuralmesotheliomawitheosinophilicpleuraleffusion
AT takahashinaoki interleukin5producingmalignantpleuralmesotheliomawitheosinophilicpleuraleffusion
AT morizumishun interleukin5producingmalignantpleuralmesotheliomawitheosinophilicpleuraleffusion
AT tamiyahiroyuki interleukin5producingmalignantpleuralmesotheliomawitheosinophilicpleuraleffusion
AT matsuokahisashi interleukin5producingmalignantpleuralmesotheliomawitheosinophilicpleuraleffusion
AT kurodanaoto interleukin5producingmalignantpleuralmesotheliomawitheosinophilicpleuraleffusion
AT yoritakenji interleukin5producingmalignantpleuralmesotheliomawitheosinophilicpleuraleffusion